OWC Pharmaceutical Company Executives

OWCP Stock  USD 0.0001  0.00  0.00%   
OWC Pharmaceutical employs about 9 people. The company is managed by 6 executives with a total tenure of roughly 6 years, averaging almost 1.0 years of service per executive, having 1.5 employees per reported executive. Discussion of OWC Pharmaceutical's management performance can provide insight into the enterprise performance.
Ziv Turner  Insider
Chief Officer
Pr Ramot  Insider
Consultant
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OWC Pharmaceutical Research. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

OWC Pharmaceutical Management Team Effectiveness

The company has return on total asset (ROA) of (0.6448) % which means that it has lost $0.6448 on every $100 spent on assets. This is way below average. OWC Pharmaceutical's management efficiency ratios could be used to measure how well OWC Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.

OWC Pharmaceutical Workforce Comparison

OWC Pharmaceutical Research is rated below average in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is now estimated at about 3,885. OWC Pharmaceutical adds roughly 9.0 in number of employees claiming only tiny portion of equities under Drug Manufacturers—Specialty & Generic industry.

OWC Pharmaceutical Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. OWC Pharmaceutical Price Series Summation is a cross summation of OWC Pharmaceutical price series and its benchmark/peer.

OWC Pharmaceutical Notable Stakeholders

An OWC Pharmaceutical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as OWC Pharmaceutical often face trade-offs trying to please all of them. OWC Pharmaceutical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting OWC Pharmaceutical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Shmuel DeSabanCFO SecProfile
Ziv TurnerChief OfficerProfile
Pr RamotConsultantProfile
Oron DVMChief OfficerProfile
Alon SinaiChief OfficerProfile
Yehuda BaruchChief Science OfficerProfile

About OWC Pharmaceutical Management Performance

The success or failure of an entity such as OWC Pharmaceutical often depends on how effective the management is. OWC Pharmaceutical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of OWC management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the OWC management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
OWC Pharmaceutical Research Corp., through its subsidiary, One World Cannabis Ltd., engages in the research and development of cannabis-based medical products. OWC Pharmaceutical Research Corp. was founded in 2008 and is based in Ramat Gan, Israel. Owc Pharmaceutical is traded on OTC Exchange in the United States.

OWC Pharmaceutical Workforce Analysis

Traditionally, organizations such as OWC Pharmaceutical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare OWC Pharmaceutical within its industry.

OWC Pharmaceutical Manpower Efficiency

Return on OWC Pharmaceutical Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee1.1M
Net Loss Per Executive1.7M

Additional Tools for OWC Pink Sheet Analysis

When running OWC Pharmaceutical's price analysis, check to measure OWC Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OWC Pharmaceutical is operating at the current time. Most of OWC Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of OWC Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OWC Pharmaceutical's price. Additionally, you may evaluate how the addition of OWC Pharmaceutical to your portfolios can decrease your overall portfolio volatility.